Tandem peptide receptor radionuclide therapy using 90Y/177Lu-DOTATATE for neuroendocrine tumors efficacy and side-effects - polish multicenter experience - Concepedia

Concepedia

Publication | Open Access

Tandem peptide receptor radionuclide therapy using 90Y/177Lu-DOTATATE for neuroendocrine tumors efficacy and side-effects - polish multicenter experience

DOI Full Paper Access

53

Citations

30

References

2020

Year

Jolanta Kunikowska, Anna Zemczak, Maciej Kołodziej, Paweł Gut, Izabela Łoń, Dariusz Pawlak, Renata Mikołajczak, Grzegorz Kamiński, Marek Ruchała, Beata Kos‐Kudła,

European Journal of Nuclear Medicine and Molecular Imaging

Abstract

This multicenter trial showed that tandem <sup>90</sup>Y/<sup>177</sup>Lu-DOTATATE is highly effective and safe therapy for patients with disseminated NET.

References

	Year	Citations

Page 1